Sandbox c16

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 6: Line 6:
It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease.
It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease.
-
<scene name='Sandbox_c16/Modificacion_2/1'>Tacrine´s</scene> ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (<scene name='Sandbox_c16/Modificacion_1/1'>W84 and F330</scene> ).
+
<scene name='Sandbox_c16/Modificacion_2/1'>Tacrine</scene> ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (<scene name='Sandbox_c16/Modificacion_1/1'>W84 and F330</scene> ).
<references/>
<references/>
Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL. Quaternary ligand binding <ref>PMDI 8415649</ref>
Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL. Quaternary ligand binding <ref>PMDI 8415649</ref>
[http://www.pubmed.com publicaciones medicas] <references/>
[http://www.pubmed.com publicaciones medicas] <references/>

Revision as of 13:27, 23 November 2010

Estructura acetilcolinesterasa

acelit colinesterasa

Drag the structure with the mouse to rotate

1ACJ shows the crystal structure of Torpedo californica acetylcholinesterase (TcAChE) complexed with tacrine. Tacrine is a parasympathomimetic and a centrally acting cholinesterase inhibitor.

It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease.

ring is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 ( ).


Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL. Quaternary ligand binding [1]

publicaciones medicas
  1. PMDI 8415649
Personal tools